Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Oral Powder" patented technology

Oral powder mixture with small particle size

UndeterminedES3072802T3Oral PowderOral medication
The invention relates to a powder mixture for the oral administration of active ingredients. The powder mixture comprises a particle population and one or more active ingredients. The particle population includes at least two types of sugar alcohol particles, wherein: at least one of said at least two types of sugar alcohol particles comprises i) non-directly compressible (non-DC) sugar alcohol particles or ii) directly compressible (DC) sugar alcohol particles that are not granulated sugar alcohol particles; at least one of said at least two types of sugar alcohol particles has a particle size with more than 50% of the particles below 250 microns; and at least one of said at least two types of sugar alcohol particles is present in an amount of at least 20% by weight of the powder mixture.

Slow-release oral powder for treating osteoporosis and preparation method thereof

PendingCN121731324AOrganic active ingredientsPowder deliveryBone densityOsteoporotic bone
The invention discloses sustained-release oral powder for treating osteoporosis and a preparation method of the sustained-release oral powder. The sustained-release oral powder comprises 2 parts of a supramolecular metal organic framework material sMOF, 0.8-1.0 part of microcrystalline cellulose and 0.1-0.2 part of magnesium stearate. Wherein the supramolecular metal organic framework material sMOF is formed by coordination self-assembly of Sr < 2 + >, Mg < 2 + >, alendronate (ALN), 1, 6-fructose diphosphate sodium salt (FDP) and casein phosphopeptides (CPP). The powder has excellent treatment effect, biocompatibility and slow release characteristic, can effectively promote osteoblast differentiation, inhibit osteoclast activity and reverse bone mineral density decline, and is suitable for treatment of bone diseases such as osteoporosis and fracture.
Owner:AFFILIATED HOSPITAL OF NANTONG UNIV